1. Home
  2. ADCT vs UNTY Comparison

ADCT vs UNTY Comparison

Compare ADCT & UNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADCT
  • UNTY
  • Stock Information
  • Founded
  • ADCT 2011
  • UNTY 1991
  • Country
  • ADCT Switzerland
  • UNTY United States
  • Employees
  • ADCT N/A
  • UNTY N/A
  • Industry
  • ADCT Biotechnology: Pharmaceutical Preparations
  • UNTY Major Banks
  • Sector
  • ADCT Health Care
  • UNTY Finance
  • Exchange
  • ADCT Nasdaq
  • UNTY Nasdaq
  • Market Cap
  • ADCT 398.2M
  • UNTY 458.0M
  • IPO Year
  • ADCT 2020
  • UNTY 1997
  • Fundamental
  • Price
  • ADCT $3.33
  • UNTY $52.06
  • Analyst Decision
  • ADCT Strong Buy
  • UNTY Buy
  • Analyst Count
  • ADCT 6
  • UNTY 3
  • Target Price
  • ADCT $7.80
  • UNTY $56.00
  • AVG Volume (30 Days)
  • ADCT 711.4K
  • UNTY 28.4K
  • Earning Date
  • ADCT 11-06-2025
  • UNTY 10-10-2025
  • Dividend Yield
  • ADCT N/A
  • UNTY 1.08%
  • EPS Growth
  • ADCT N/A
  • UNTY 30.37
  • EPS
  • ADCT N/A
  • UNTY 4.94
  • Revenue
  • ADCT $77,246,000.00
  • UNTY $116,265,000.00
  • Revenue This Year
  • ADCT $12.71
  • UNTY $23.79
  • Revenue Next Year
  • ADCT $6.59
  • UNTY $9.20
  • P/E Ratio
  • ADCT N/A
  • UNTY $10.51
  • Revenue Growth
  • ADCT 15.73
  • UNTY 17.14
  • 52 Week Low
  • ADCT $1.05
  • UNTY $31.44
  • 52 Week High
  • ADCT $3.97
  • UNTY $54.64
  • Technical
  • Relative Strength Index (RSI)
  • ADCT 56.37
  • UNTY 57.27
  • Support Level
  • ADCT $3.04
  • UNTY $51.72
  • Resistance Level
  • ADCT $3.59
  • UNTY $53.05
  • Average True Range (ATR)
  • ADCT 0.17
  • UNTY 1.30
  • MACD
  • ADCT 0.03
  • UNTY 0.12
  • Stochastic Oscillator
  • ADCT 55.65
  • UNTY 80.20

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

About UNTY Unity Bancorp Inc.

Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. It conducts a traditional and community-oriented commercial banking business and offers services, including personal and business checking accounts, time deposits, money market accounts, regular savings accounts, and others. The company structures its specific services and charges in a manner designed to attract the business of small and medium-sized businesses and professional communities, as well as individuals residing, working, and shopping in its service area. The company engages in a wide range of lending activities and offers commercial, Small Business Administration, consumer, mortgage, home equity, and personal loans.

Share on Social Networks: